GSE232624 4 V 5 ETHANOL HUMAN DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE232624 4 V 5 ETHANOL HUMAN DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE232624 4 V 5 ETHANOL HUMAN DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE232624 4 V 5 ETHANOL HUMAN DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE232624 4 V 5 ETHANOL HUMAN DN.

Results found

Linked to

 

Label

Description

 

Gene

gametogenetin binding protein 2

Gene

colony stimulating factor 2 receptor subunit alpha

Gene

leukocyte receptor cluster member 9

Gene

zinc finger protein 722

Gene

cell death inducing p53 target 1

Gene

SRY-box transcription factor 6

Gene

splicing regulatory glutamic acid and lysine rich protein 1

Gene

PPP1R2 family member B

Gene

FCF1 rRNA-processing protein

Gene

DEAH-box helicase 38

  • Gene

    gametogenetin binding protein 2


  • Gene

    colony stimulating factor 2 receptor subunit alpha


  • Gene

    leukocyte receptor cluster member 9


  • Gene

    zinc finger protein 722


  • Gene

    cell death inducing p53 target 1


  • Gene

    SRY-box transcription factor 6


  • Gene

    splicing regulatory glutamic acid and lysine rich protein 1


  • Gene

    PPP1R2 family member B


  • Gene

    FCF1 rRNA-processing protein


  • Gene

    DEAH-box helicase 38

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.